MIR4513

Across TCGA pan-cancer cohorts, MIR4513 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated MIR4513 data layer.

The strongest signal is observed in mesothelioma (MESO), where higher MIR4513 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4513 expression acts as an unfavorable survival marker, although some lineages such as BLCA and HNSC show a favorable association.

MESO, LGG, and KICH are the cancer types where MIR4513 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
MESO	OS	Quartile	II,III,IV	0.178	0.654	.001	120	view →
LGG	DFS	Tertile	All	0.758	0.854	.001	25	view →
KICH	OS	Tertile	II,III,IV	0.876	1.000	.016	24	view →
BLCA	DFS	Tertile	All	0.503	0.298	.024	21	view →
ESCA	DFS	Median	IV	0.205	0.634	.006	18	view →
UCS	OS	Tertile	All	0.419	0.706	.036	18	view →
ACC	OS	Tertile	IV	0.327	0.633	.045	18	view →
HNSC	DFS	Tertile	III,IV	0.446	0.314	.027	18	view →
CHOL	OS	Tertile	All	0.815	0.491	.043	12	view →
READ	DFS	Tertile	IV	0.095	0.697	.014	9	view →
COAD	OS	Tertile	III,IV	0.530	0.761	.019	8	view →
TGCT	DFS	Quartile	All	0.959	0.794	.017	4	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

MIR4513–MESO (OS)

Open the MESO breakdown →